These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30416197)

  • 1. Genotype Matters in Patients with Acute-on-chronic Liver Failure Due to Reactivation of Chronic Hepatitis B.
    Wan YM; Li YH; Xu ZY; Wu HM; Wu XN; Xu Y
    Clin Transl Gastroenterol; 2018 Nov; 9(11):202. PubMed ID: 30416197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenofovir Versus Entecavir for the Treatment of Acute-on-Chronic Liver Failure due to Reactivation of Chronic Hepatitis B With Genotypes B and C.
    Wan YM; Li YH; Xu ZY; Wu HM; Xu Y; Wu XN; Yang JH
    J Clin Gastroenterol; 2019 Apr; 53(4):e171-e177. PubMed ID: 29659382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entecavir vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
    Zhang Y; Hu XY; Zhong S; Yang F; Zhou TY; Chen G; Wang YY; Luo JX
    World J Gastroenterol; 2014 Apr; 20(16):4745-52. PubMed ID: 24782628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure.
    Lai J; Yan Y; Mai L; Zheng YB; Gan WQ; Ke WM
    Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):154-9. PubMed ID: 23558069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure.
    Sun LJ; Yu JW; Zhao YH; Kang P; Li SC
    J Gastroenterol Hepatol; 2010 Mar; 25(3):583-90. PubMed ID: 19968744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Study of Treatment Outcome with Tenofovir Alafenamide and Entecavir in Patients with HBV Related Acute on Chronic Liver Failure.
    Somon MAU; Shwapnil MAM; Debnath CR; Noor-E-Alam SM; Tarafdar AJ; Ahmad MF; Ashrafujjaman M; Jhily KRA; Ashiq MS; Hasan MZ
    Mymensingh Med J; 2024 Jul; 33(3):696-705. PubMed ID: 38944709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
    Garg H; Sarin SK; Kumar M; Garg V; Sharma BC; Kumar A
    Hepatology; 2011 Mar; 53(3):774-80. PubMed ID: 21294143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score.
    Li X; Gao F; Liu H; Zhang H; Liu Y; Ye X; Geng M; Sun L; Wang R; Li Y; Jiang Y; Wang X; Zhou G; Yang Z; Li A; Zeng H; Wang X
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):1-9. PubMed ID: 27749778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [To investigate the opportunity of entecavir treatment for HBeAg-negative acute-on-chronic liver].
    Mai L; Yan Y; Zhang SQ; Ke WM; Cao H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Aug; 27(4):286-8. PubMed ID: 24579477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.
    Park JG; Park SY
    Clin Mol Hepatol; 2015 Sep; 21(3):242-8. PubMed ID: 26523269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis?
    Lei JH; Peng F; Chen Z; Xiao XQ
    BMC Infect Dis; 2019 Apr; 19(1):363. PubMed ID: 31039732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients?
    Yan Y; Mai L; Zheng YB; Zhang SQ; Xu WX; Gao ZL; Ke WM
    World J Gastroenterol; 2012 Sep; 18(33):4604-9. PubMed ID: 22969236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B.
    Park JG; Lee YR; Park SY; Lee HJ; Tak WY; Kweon YO; Jang SY; Chun JM; Han YS; Hur K; Lee HW; Kang MK
    Dig Liver Dis; 2018 Feb; 50(2):163-167. PubMed ID: 29089265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis.
    Yue-Meng W; Li YH; Wu HM; Yang J; Xu Y; Yang LH; Yang JH
    Clin Exp Med; 2017 May; 17(2):233-241. PubMed ID: 27094312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of tenofovir alafenamide and entecavir for hepatitis B virus
    Peng W; Gu H; Jiang C; Liu J; Zhang J; Fu L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):194-201. PubMed ID: 35545409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Lamivudine Versus Entecavir for Treating Chronic Hepatitis B Virus-related Acute Exacerbation and Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis.
    Huang KW; Tam KW; Luo JC; Kuan YC
    J Clin Gastroenterol; 2017 Jul; 51(6):539-547. PubMed ID: 28067752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance.
    Lee S; Ahn SH; Jung KS; Kim DY; Kim BK; Kim SU; Baatarkhuu O; Ku HJ; Han K; Park JY
    J Viral Hepat; 2017 Feb; 24(2):141-147. PubMed ID: 27766731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effect of entecavir versus tenofovir in treatment of HBeAg-positive chronic hepatitis B patients with a high viral load: a comparative analysis].
    Shi H; Li XY; Zhu JY; Lin CS; Zhang Y
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):721-725. PubMed ID: 29108198
    [No Abstract]   [Full Text] [Related]  

  • 19. Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures.
    Zhang Q; Han T; Nie CY; Ha FS; Liu L; Liu H
    J Med Virol; 2015 Jun; 87(6):1013-21. PubMed ID: 25716029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy.
    Reijnders JG; Pas SD; Schutten M; de Man RA; Janssen HL
    J Hepatol; 2009 Apr; 50(4):674-83. PubMed ID: 19231002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.